Rare diseases
Investigational molecules
Locations
279 Princeton Hightstown Road, 08520-1401, United States
Acrotech Biopharma Inc. demonstrates a focused commitment to advancing therapeutic options for patients with complex blood cancers and lymphoid system malignancies. The company's research portfolio encompasses a comprehensive approach to treating various forms of lymphoma and related hematologic conditions, with particular emphasis on T-cell lymphomas and B-cell malignancies.
The sponsor's investigational efforts extend to challenging subtypes including mycosis fungoides, Sézary syndrome, and enteropathy-associated T-cell lymphoma, reflecting a dedication to addressing rare and difficult-to-treat hematologic conditions. Research activities also encompass primary cutaneous CD30-positive T-cell lymphoproliferative disorders and various forms of nodal lymphomas, including follicular lymphoma and diffuse large B-cell lymphoma.
Acrotech Biopharma Inc. runs clinical trials in conditions such as Peripheral T-cell lymphoma unspecified, among others.
Clinical trials run by this sponsor – those enrolling participants first.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
